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The presence of different APOE isoforms represents a well-known risk factor for cardio-
vascular diseases. Besides the pleiotropic effects of APOE polymorphism on heart and
neurological diseases, this review summarizes the less-known functions of APOE and
the possible implications for cardiovascular disorders. Beyond the role as lipid transport-
ing protein, its involvement in lipid membrane homeostasis and signaling, as well as its
nuclear transcriptional effects suggests a more complex role of APOE, receiving great in-
terest from researchers and physicians from all medical fields. Due to the presence of
different APOE isoforms in human population, understanding APOE’s role in patholog-
ical processes represents not only a challenge, but a demand for further development of
therapeutic strategies for cardiovascular diseases.  2018 IMSS. Published by Elsevier
Inc.
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Introduction
Apolipoprotein E (APOE) is a ubiquitous protein, essential
for the lipid metabolism in all tissues and organs. Because
of the numerous evidences about APOE involvement in a
wide range of chronic conditions, it is believed that its role
is widely known and accepted. Nevertheless, the multifunc-
tional role of APOE beyond its involvement in lipid metab-
olisms, made it become a real biologic enigma. In this
review, we summarize well-known effects of APOE, as well
as their lipid-independent effects in different pathological
conditions, trying to speculate the dimension of the conse-
quences on cardiovascular diseases.
The Well-known Face of Apolipoprotein E
APOE is a protein member of soluble apolipoproteins,
coded by three alleles (ε2, ε3, ε4) (1). Thus, these alleles
give six phenotypes (from most to least common subse-
quently: ε3/ε3, ε4/ε3, ε3/ε2, ε4/ε4, ε4/ε2, and ε2/ε2) (2).
Although APOE is synthesized mainly by liver (3), many
other cells and tissues are able to synthesized APOE, such
as macrophages, adipocytes, smooth muscle cells, brain or
kidney (4,5). One of the major functions of APOE is to
maintain cholesterol homeostasis and lipoprotein clearance
from circulation. Lipids absorbed from the intestine are
transported to different tissues by chylomicrons particles
via lymphatic system. After restoring tissue energetic re-
serves and/or adipocyte lipid storage, chylomicrons acquire
APOE, which acts as a ligand for cell-surface receptors of
low-density lipoprotein receptor (LDLR) family. Thus, the
liver cells possessing low density lipoprotein
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